Antonella Folgori

Antonella Folgori
  • Antonella is co-founder and Director of Immunology Department of Keires and NOUSCOM, two companies dedicated to the development of novel technologies for the prevention and cure of cancer and chronic diseases.
  • She received her degree in Biology and a PhD in Molecular and Cellular Biology from the University of Rome “La Sapienza”. As a PhD student she worked at IRBM (“Istituto di Ricerche di Biologia Molecolare”) in Pomezia, where she focused her research interest in the field of diagnosis and prevention of chronic infectious diseases.
  • She conducted post-doctoral studies at the “Institute de Genetique et de Biologie Moleculaire et Cellulaire” (IGBMC) in Strasbourg, France and then moved back to IRBM.
  • She was co-founder and Director of the Immunology Department of Okairos a biotech dedicated to the development of innovative vaccines for major infectious diseases, which was acquired by GlaxoSmithKline in 2013.
  • She has authored several scientific publications on subjects including peptide phage display technology, immunology, viral infections and vaccines.
  • She received her degree in Biology in 1991 and a PhD in Molecular and Cellular Biology from the University of Rome “La Sapienza” in 1994.
  • As a PhD student she worked at IRBM (“Istituto di Ricerche di Biologia Molecolare”) in Pomezia, where she focused her research interest in the field of diagnosis and prevention of chronic infectious diseases.
  • She conducted post-doctoral studies at the “Institute de Genetique et de Biologie Moleculaire et Cellulaire” (IGBMC) in Strasbourg, France.
  • In 1997 she moved back to IRBM where has been the leading scientist of the HCV vaccine project.
  • She was co-founder and Director of the Immunology Department of Okairos a biotech dedicated to the development of genetic vaccines for major infectious diseases, which was acquired by GlaxoSmithKline (GSK) in 2013.
Share

Download Our Flyer!